Construction planning and plant /

Por Ackernan, A. J., Locher, C. H.
Publicado em 1940

Artificial intelligence and the future of psychiatry: Qualitative findings from a global physician survey

Por Blease, C, Locher, C, Leon-Carlyle, M, Doraiswamy, M
Publicado no Digit Health (2020)

Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals.

Por Locher, C, Vanham, G, Kestens, L, Kruger, M, Ceuppens, J L, Vingerhoets, J, Gigase, P
Publicado em 1994

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer

Por Chaput, N, Svrcek, M, Aupérin, A, Locher, C, Drusch, F, Malka, D, Taïeb, J, Goéré, D, Ducreux, M, Boige, V
Publicado em 2013

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

Por Aparicio, T, Desramé, J, Lecomte, T, Mitry, E, Belloc, J, Etienney, I, Montembault, S, Vayre, L, Locher, C, Ezenfis, J, Artru, P, Mabro, M, Dominguez, S
Publicado em 2003

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines

Por Hannani, D, Locher, C, Yamazaki, T, Colin-Minard, V, Vetizou, M, Aymeric, L, Viaud, S, Sanchez, D, Smyth, M J, Bruhns, P, Kroemer, G, Zitvogel, L
Publicado em 2014

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

Por Yamazaki, T, Hannani, D, Poirier-Colame, V, Ladoire, S, Locher, C, Sistigu, A, Prada, N, Adjemian, S, Catani, J PP, Freudenberg, M, Galanos, C, André, F, Kroemer, G, Zitvogel, L
Publicado em 2014

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

Por Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P
Publicado em 2013

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)